AI assistant
Indoco Remedies Ltd. — Call Transcript 2024
Oct 15, 2024
62453_rns_2024-10-15_7f00544c-9fbe-42d9-b1fd-1a6cc5dc3f67.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [199 x 70] intentionally omitted <==
October 15, 2024
| To The Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra–Kurla Complex Bandra (East) Mumbai– 400 051 Stock Code : INDOCO-EQ |
To The Listing Department Bombay Stock Exchange Limited Floor 25, P. J. Towers, Dalal Street, Mumbai– 400 001 _Stock Code :_532612 |
|
|---|---|---|
Dear Sir/Madam,
Sub : Intimation of Earnings Conference Call on unaudited financial results for quarter and half year ended 30[th] September, 2024
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings Conference Call on Unaudited Financial Results for the quarter and half year ended 30[th] September, 2024 is scheduled to be held on Thursday, 24[th] October, 2024 at 03:30 P.M. IST.
The details of the conference call are enclosed herewith.
This is for your information and dissemination on respective websites.
Thanking you,
Yours faithfully,
For Indoco Remedies Limited
RAMANATHA Digitally signed by RAMANATHAN N HARIHARAN Date: 2024.10.15 HARIHARAN 18:17:14 +05'30' Ramanathan Hariharan
Company Secretary & Head Legal
==> picture [592 x 76] intentionally omitted <==
==> picture [515 x 81] intentionally omitted <==
You are cordially invited to the Q2 FY25 Earnings Conference Call of Indoco Remedies Limited
on
Thursday, October 24, 2024 at 3:30PM IST
Represented by: Ms. Aditi Panandikar Managing Director Mr. Sundeep V Bambolkar Jt. Managing Director Mr. Pramod Ghorpade CFO
Pre-register to avoid the waiting queue, join with DiamondPass link: Registration Link
Conference Dial-In Number
+91 22 6280 1116 Universal Access +91 22 7115 8017
International Toll Free
Hong Kong : 800 964 448 Singapore : 800 101 2045 USA : 1 866 746 2133 UK : 0 808 101 1573
For further information, please contact:
Rashmi Shetty
Candice Pereira
VP – Research (Pharma) Associate (Pharma) Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. (D) +91 22 40969724/8879111413 (D) +91 22 40979633/9833458572 Email: [email protected] Email: [email protected]
Zain Gulam Hussain
Associate (Pharma) Dolat Capital Market Pvt. Ltd. (D) +91 22 40979790/9892724209 Email: [email protected]